Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (HK:3320)
:3320
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 274.18B | HK$ 270.40B | HK$ 254.11B | HK$ 236.81B | HK$ 200.42B |
| Gross Profit | HK$ 43.30B | HK$ 43.37B | HK$ 39.13B | HK$ 35.38B | HK$ 32.29B |
| Operating Income | HK$ 12.90B | HK$ 12.15B | HK$ 10.81B | HK$ 9.25B | HK$ 8.47B |
| EBITDA | HK$ 15.45B | HK$ 15.43B | HK$ 15.47B | HK$ 11.95B | HK$ 12.47B |
| Net Income | HK$ 3.57B | HK$ 3.85B | HK$ 3.50B | HK$ 3.08B | HK$ 2.78B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 17.48B | HK$ 59.27B | HK$ 32.52B | HK$ 37.32B | HK$ 52.34B |
| Total Assets | HK$ 274.28B | HK$ 271.48B | HK$ 241.29B | HK$ 248.56B | HK$ 209.37B |
| Total Debt | HK$ 73.43B | HK$ 62.16B | HK$ 67.00B | HK$ 82.59B | HK$ 58.63B |
| Net Debt | HK$ 55.95B | HK$ 37.51B | HK$ 42.88B | HK$ 57.26B | HK$ 40.91B |
| Total Liabilities | HK$ 169.90B | HK$ 169.20B | HK$ 150.24B | HK$ 152.69B | HK$ 128.69B |
| Stockholders' Equity | HK$ 51.34B | HK$ 50.60B | HK$ 49.56B | HK$ 50.98B | HK$ 46.47B |
| Cash Flow | |||||
| Free Cash Flow | HK$ 14.33B | HK$ 12.42B | HK$ 7.54B | HK$ 8.32B | HK$ 4.06B |
| Operating Cash Flow | HK$ 17.55B | HK$ 15.55B | HK$ 10.90B | HK$ 11.22B | HK$ 6.28B |
| Investing Cash Flow | HK$ 0.00 | HK$ -2.07B | HK$ -3.30B | HK$ -8.83B | HK$ -2.02B |
| Financing Cash Flow | HK$ 0.00 | HK$ -4.07B | HK$ -9.00B | HK$ 5.31B | HK$ -3.60B |